Addiction

Drug use severity in adolescence affects substance use disorder risk in adulthood

Scientific article

Although more than 1 in every 3 US individuals will develop a substance use disorder in their lifetime, relatively little is known about the long-term patterns of substance use disorder symptoms from adolescence through adulthood. Key...

The 2022 APSAD Conference

9 October 2022

Darwin

Australia

The 2022 APSAD Conference will take place from 9-12 October 2022.

Since 1981, APSAD has been bringing together diverse perspectives in relation to research, policy, and practice from across the AOD sector to share, discuss, and present on evidence-based issues.

The Intersection of DEA, Opioids, and MAT

27 April 2022

Online

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted

UNODC Trains Team of National Trainers from Central Asia within the Advanced Level of the Universal Treatment Curriculum for Substance Use Disorders

News

The UNODC Regional Office for Central Asia supported a training of trainers (ToT) on Course 13 – “Contingency Management: A Reinforcement Based Treatment” and “Course 18 – “Clinical Supervision” which took place in person in Bishkek...

Differences in addiction and recovery gains according to gender – gender barriers and specific differences in overall strengths growth

Scientific article

14 March 2022

Background The necessity of a gendered understanding of recovery is becoming increasingly evident. There have been reports of gender disparities in the character and amount of substance use, the paths to and through substance use disorder...

Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic

Scientific article

18 March 2022

Background The long-running opioid epidemic and the more recent COVID-19 pandemic are two interrelated events with major public health implications for people who use opioids (OUD). The majority of studies on the interaction of these two...

Let’s Talk Overdose 2022

6 April 2022

Online

2-DAY CONFERENCE

April 6, 2022
Early risk – Early intervention: Overdose among Youth

Changing drug markets and the COVID-19 pandemic have created an increasingly serious need to develop specific solutions for young people at risk of overdose. Everyone is welcome to join the conversations about early intervention, prevention and youth-focused treatments for high-risk substance use.

Non-opioid prescription misuse

Video and audio recordings

This presentation explored the who, how and why of non-opioid prescription drug misuse focusing on antipsychotics, stimulants and pregabalin. While much is known about the prevalence and associated harms of prescription opioid and...

Effects of extended-release buprenorphine treatment for opioid dependence

Video and audio recordings

In this webinar, findings were reported from the CoLAB qualitative study, which aimed to examine the multiple social, material and temporal effects of extended-release buprenorphine depot (BUP-XR) treatment in clients’ lives, among a group...

INEBRIA Edinburgh 2022

21 September 2022

Edinburgh

United Kingdom

INEBRIA is an international network of researchers, policymakers, practitioners and other stakeholders interested in the potential of brief interventions in health and other settings to reduce the harms produced by alcohol and other drug use.

Addiction

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

2-DAY CONFERENCE

April 6, 2022 Early risk – Early intervention: Overdose among Youth

April 6, 2022
Early risk – Early intervention: Overdose among Youth